97-15843. Manufacturer of Controlled Substances; Notice of Application  

  • [Federal Register Volume 62, Number 116 (Tuesday, June 17, 1997)]
    [Notices]
    [Page 32824]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-15843]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Application
    
        Pursuant to Section 1301.33 of Title 21 of the Code of Federal 
    Regulations (CFR), this is notice that on May 13, 1997, Damocles10, 
    3529 Lincoln Highway, Thorndale, Pennsylvania 19372, made application 
    by renewal to the Drug Enforcement Administration (DEA) for 
    registration as a bulk manufacturer of the basic classes of controlled 
    substances listed below:
    
    ------------------------------------------------------------------------
                        Drug                               Schedule         
    ------------------------------------------------------------------------
    Heroin (9200)..............................  I                          
    Codeine (9050).............................  II                         
    Hydromorphone (9150).......................  II                         
    Hydrocodone (9193).........................  II                         
    Morphine (9300)............................  II                         
    ------------------------------------------------------------------------
    
        The firm plans to manufacture the listed controlled substances for 
    the purpose of deuterium labeled internal standards for distribution to 
    analytical laboratories.
        Any other such applicant and any person who is presently registered 
    with DEA to manufacture such substances may file comments or objections 
    to the issuance of the proposed registration.
        Any such comments or objections may be addressed, in quintuplicate, 
    to the Deputy Assistant Administrator, Office of Diversion Control, 
    Drug Enforcement Administration, United States Department of Justice, 
    Washington, D.C. 20537, Attention: DEA Federal Register Representative, 
    (CCR), and must be filed no later than August 18, 1997.
    
        Dated: June 9, 1997.
    John H. King,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 97-15843 Filed 6-16-97; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
06/17/1997
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
97-15843
Pages:
32824-32824 (1 pages)
PDF File:
97-15843.pdf